Search

Your search keyword '"Niedoszytko, Marek"' showing total 644 results

Search Constraints

Start Over You searched for: Author "Niedoszytko, Marek" Remove constraint Author: "Niedoszytko, Marek"
644 results on '"Niedoszytko, Marek"'

Search Results

1. Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis: CHRONIC MYELOPROLIFERATIVE NEOPLASMS

2. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts

3. Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM

4. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

5. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

6. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

7. Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study

8. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

9. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives

10. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

11. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

12. Cutoff Values of MASK-air Patient-Reported Outcome Measures

13. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis

14. Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study

15. Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond

16. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

17. Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

18. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

19. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

20. Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.

21. IL-4, TSLP and IL-31 Cytokine Profiles as Related to Psychometric Measures in Patients with Mastocytosis.

22. Role of sclerostin in mastocytosis bone disease.

23. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

24. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

25. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis

26. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

27. Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin

28. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

29. Basophil Activation Test Is Inferior to Provocation Test in Diagnosing Aspirin Hypersensitivity.

30. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

31. Venom Immunotherapy Does Not Affect Survival of Patients with Malignant Tumor in Poland

32. Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry

34. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

35. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

36. International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

37. Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

39. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

40. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

42. The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.

43. Stanowisko Sekcji Anafilaksji, Alergii na Jady Owadów i Mastocytozy Polskiego Towarzystwa Alergologicznego dotyczące zasad diagnostyki nadwrażliwości na jad owadów błonkoskrzydłych.

44. The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives

46. Analysis of Allergy and Hypersensitivity Reactions to COVID-19 Vaccines According to the EudraVigilance Database.

47. Stanowisko grupy ekspertów Polskiego towarzystwa Alergologicznego w sprawie postępowania u chorych na astmę i choroby alergiczne w okresie pandemii SARS-coV-2.

49. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

50. Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis

Catalog

Books, media, physical & digital resources